Univest
Univest
  • Markets

AksharChem India Q4 FY26 Results: PAT Rs 5 Cr

  • May 22, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments

AksharChem India Q4 FY26 results were declared on May 21, 2026. The company reported PAT of Rs 5 crore for the quarter ended March 31, 2026, up 400.0% YoY compared to Rs 1 crore in Q4 FY25. Revenue from operations stood at Rs 106 crore, up 16.0% YoY. Results are on a Standalone basis. AksharChem India is a Specialty Chemicals company listed on Indian stock exchanges.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • AksharChem India Q4 FY26 Financial Highlights
  • AksharChem India Q4 FY26 Performance Analysis
  • Key Factors Driving AksharChem India Q4 FY26 Results
    • Revenue and Business Performance
    • Profitability and Margins
    • India Macro Backdrop
    • FY27 Outlook
  • Frequently Asked Questions on the company
    • What is AksharChem India Q4 FY26 net profit?
    • What is AksharChem India Q4 FY26 revenue?
    • When were AksharChem India Q4 FY26 results declared?
    • Is AksharChem India a good investment after Q4 FY26?

AksharChem India Q4 FY26 Financial Highlights

Metric Q4 FY26 (Rs Cr) Q4 FY25 (Rs Cr) YoY Change
Revenue 106 91 +16.0%
Gross Profit Rs 1 crore 3 -66.0%
Net Profit 5 1 +400.0%
Basis Standalone

Note: AksharChem India Q4 FY26 results declared May 21, 2026. Verify from BSE/NSE audited filings before investment decisions.

AksharChem India Q4 FY26 Performance Analysis

The AksharChem India Q4 FY26 results reflect the company’s operational performance in the January to March 2026 quarter. Strong PAT growth of 400% YoY to Rs 5 crore demonstrates significant earnings improvement. AksharChem India operates in the Specialty Chemicals sector, which benefited from India’s GDP growth above 6.5% in FY26.

Revenue grew 16% YoY to Rs 106 crore, driven by strong demand and business expansion.

Screen the best stocks on the Univest Screener.

Key Factors Driving AksharChem India Q4 FY26 Results

Revenue and Business Performance

AksharChem India Q4 FY26 revenue of Rs 106 crore was up 16.0% YoY. Revenue momentum reflects steady demand in the Specialty Chemicals business.

Profitability and Margins

the business PAT of Rs 5 crore up 400.0% YoY. The strong PAT growth demonstrates improving operational leverage and cost discipline.

India Macro Backdrop

The January to March 2026 quarter benefited from India’s GDP growth above 6.5%, government capital expenditure of Rs 11.21 lakh crore for FY27, and resilient domestic consumption. RBI’s accommodative stance supported credit and demand conditions. The Specialty Chemicals sector saw strong tailwinds during this period.

FY27 Outlook

Following the firm results, management commentary on FY27 revenue guidance, margin expansion roadmap, and capital allocation will be key investor watchpoints. The Specialty Chemicals sector continues to benefit from India’s long-term structural growth.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on the company

What is AksharChem India Q4 FY26 net profit?

Ans. AksharChem India Q4 FY26 PAT of Rs 5 crore, up 400.0% YoY from Rs 1 crore in Q4 FY25. Results declared May 21, 2026, on a Standalone basis.

What is AksharChem India Q4 FY26 revenue?

Ans. AksharChem India Q4 FY26 revenue from operations was Rs 106 crore, up 16.0% YoY. Verify from BSE/NSE filings.

When were AksharChem India Q4 FY26 results declared?

Ans. AksharChem India Q4 FY26 results were declared on May 21, 2026, at the board of directors meeting approving audited Q4 and FY26 financial statements.

Is AksharChem India a good investment after Q4 FY26?

Ans. Investment decisions require individual assessment of fundamentals, valuation, and risk. This article is for educational purposes only. Consult a SEBI-registered financial advisor before investing.



News Q4 Results
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply